Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated about 4 hours ago
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
about 4 hours ago
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices...
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 3, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of...
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of authorisation: 06/05/2026, Revision: 1, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of...
Human medicines European public assessment report (EPAR): Vijoice, alpelisib, Date of authorisation: 15/07/2026, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Vijoice, alpelisib, Date of authorisation...
Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation: 19/09/2022, Revision: 15, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 30, Status: Authorised
about 6 hours ago
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation...
Orphan designation: daratumumab Treatment of AL amyloidosis, 25/05/2018 Withdrawn
about 6 hours ago
Orphan designation: daratumumab Treatment of AL amyloidosis, 25/05/2018 Withdrawn
Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Date of authorisation: 16/03/2016, Revision: 16, Status: Authorised
about 6 hours ago
Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Date of authorisation...
Human medicines European public assessment report (EPAR): Skyrizi, risankizumab, Date of authorisation: 26/04/2019, Revision: 31, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Skyrizi, risankizumab, Date of authorisation...
Start of procedure: Extension of marketing authorisation (24 July 2026 - 20 August 2026)
about 8 hours ago
Start of procedure: Extension of marketing authorisation (24 July 2026 - 20...
Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (24 July 2026 - 20 August 2026)
about 8 hours ago
Start of procedure: Type II Variation - Extension of indication under evaluation...